BIT
AGRX

BlackRock Institutional Trust’s Agile Therapeutics AGRX Stock Holding History

BlackRock Institutional Trust’s Portfolio AGRX Stock Details AGRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		$564K Hold
49
– – ﹤0.01% 3432
2016
Q3 		$690K Sell
49
-1
-2% -$14.3K ﹤0.01% 3406
2016
Q2 		$759K Buy
50
+6
+14% +$82.2K ﹤0.01% 3402
2016
Q1 		$549K Buy
44
+4
+10% +$51.6K ﹤0.01% 3437
2015
Q4 		$784K Buy
40
+1
+3% +$15.8K ﹤0.01% 3391
2015
Q3 		$522K Hold
39
– – ﹤0.01% 3488
2015
Q2 		$676K Buy
+39
New +$832K ﹤0.01% 3451
2015
Q1 		– Hold
0
– – – 3826

Other funds holding AGRX

PAI
ProQuest Associates IV Naples, Florida $53M AUM 3.35% 1-Year Est. Return
IA
Investor AB Stockholm, Sweden $15.1B AUM 29.02% 1-Year Est. Return
CC
Caxton Corporation Princeton, New Jersey $4.02M AUM 256.08% 1-Year Est. Return
AC
Aisling Capital New York $45.3M AUM 15.24% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return

BlackRock Institutional Trust's AGRX Position: Q4 2016 in Review

BlackRock Institutional Trust held its Agile Therapeutics (AGRX) position steady in Q4 2016 at 49 shares worth $564K. The position accounts for ﹤0.01% of the portfolio, ranked #3432.

BlackRock Institutional Trust first reported a position in AGRX in Q2 2015 and has held it in 7 quarters since. The position peaked at $784K in Q4 2015. 62 funds tracked by Wall St. Rank hold AGRX as of Q4 2016.

  • BlackRock Institutional Trust held 49 shares of Agile Therapeutics worth $564K as of Q4 2016.
  • BlackRock Institutional Trust left its Agile Therapeutics share count unchanged in Q4 2016.
  • Agile Therapeutics made up ﹤0.01% of BlackRock Institutional Trust's portfolio in Q4 2016, its #3432 holding.
  • BlackRock Institutional Trust first reported a position in Agile Therapeutics in Q2 2015 and has held it in 7 quarters since.
  • BlackRock Institutional Trust's Agile Therapeutics position peaked at $784K in Q4 2015.
  • 62 funds tracked by Wall St. Rank held Agile Therapeutics as of Q4 2016.

Based on BlackRock Institutional Trust's 13F filing for Q4 2016, filed 10 Feb 2017.